European Journal of Medicinal Chemistry (2020)
Update date:2022-08-15
Topics:
Suebsuwong, Chalada
Dai, Bing
Pinkas, Daniel M.
Duddupudi, Anantha Lakshmi
Li, Li
Bufton, Joshua C.
Schlicher, Lisa
Gyrd-Hansen, Mads
Hu, Ming
Bullock, Alex N.
Degterev, Alexei
Cuny, Gregory D.
Receptor-interacting protein kinase 2 (RIPK2) is a key mediator of nucleotide-binding oligomerization domain (NOD) cell signaling that has been implicated in various chronic inflammatory conditions. A new class of RIPK2 kinase/NOD signaling inhibitors bas
View MoreTianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Pengchen New Material Technology Co., Ltd.
Contact:+86-512-63680537
Address:99.6 km of national road 318, Meiyan Community,Pingwang Town, Wujiang District, Suzhou 215225
Xinchang Yueding Chemical Co., Ltd.
Contact:86-571-56926323
Address:NO.90 BEIMENCHENGWAI CHENGGUAN TOWN XINCHANG
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Doi:10.1016/0022-328X(84)85135-9
(1984)Doi:10.1021/jm00335a018
(1964)Doi:10.1016/j.bmc.2015.06.012
(2015)Doi:10.1055/s-2006-950424
(2006)Doi:10.1002/ejoc.200601067
(2007)Doi:10.1002/jlcr.3830
(2020)